Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-16-014310
Filing Date
2016-03-09
Accepted
2016-03-09 17:01:01
Documents
5
Effectiveness Date
2016-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 xene-s8_20160308.htm S-8 130271
2 EX-5.1 xene-ex51_9.htm EX-5.1 11636
3 EX-23.1 xene-ex231_8.htm EX-23.1 19553
4 GRAPHIC g201603092133045847265.jpg GRAPHIC 15580
5 GRAPHIC g201603092133062939517.jpg GRAPHIC 2469
  Complete submission text file 0001564590-16-014310.txt   187624
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210050 | Film No.: 161495196
SIC: 2834 Pharmaceutical Preparations